Navigation Links
Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study
Date:5/14/2013

BLUE BELL, Pa., May 14, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that in a preclinical study of Inovio's SynCon® DNA vaccine against Ebola and Marburg filoviruses, labeled "Category A" bioterrorism agents by the U.S. government, the vaccine induced strong and broad immune responses and demonstrated 100% protection against death following a challenge with multiple variants of the pathogen in two animal models.

There is no approved vaccine or therapy available against these highly virulent pathogens that have killed up to 90% of the people they infected. Because these viruses could potentially be easily transmitted, result in high mortality rates and cause a major public health impact, various agencies are seeking solutions for public health preparedness. A DNA vaccine could offer faster design and manufacturing timelines than traditional vaccine approaches, but particularly important, Inovio's SynCon® products offer the potentially preemptive advantage of enabling a design to provide broad protection encompassing multiple families of these so-called filoviruses.

Preclinical data was published in the peer-reviewed journal Molecular Therapy in a paper, "Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and Ebola," authored by Inovio researchers and collaborators.

Using Inovio's proprietary SynCon® design approach, Inovio researchers developed a polyvalent DNA vaccine consisting of three consensus plasmids to broadly target variant virus strains within three distinct families of Ebola and Marburg viruses. In the first part of this study, following two vaccinations using Inovio's proprietary CELLECTRA® electroporation device, 100% of vaccinated guinea pigs were protected from death following a virus challenge. The researchers observed significant increases in neutr
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/rt3mhz/deciphering ... "Deciphering Global Major Pharmaceutical Companies, New Outsourcing Demands ... It has been publicly recognized that global ... series of challenges in the recent years. The ... in small molecule product manufacturing; increasingly challenging process ...
(Date:7/7/2015)... 7, 2015   Decision Resources Group ... dialysis patient management in the U.S. versus the ... U.S. and EU5 nephrologists from approximately 1,870 dialysis ... the most commonly used renal medications in dialysis ... considerably between the two regions.      Other ...
(Date:7/7/2015)... BANGALORE , July 7, 2015 ... innovative clinical trial data management solutions, has been featured ... publication named " EDC and eCOA / ePRO Market ... is one of the leading providers of research and ... 22 EDC and eCOA / ePRO tools in the ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... Minimally Invasive Surgery Symposium (MISS) will include discussion of ... surgery, single-port bariatric surgery, transoral gastroplasty, and other "frontier" ... by MISS Executive Director Philip R Schauer, MD, on ... , The five-day CME conference, which will be held ...
... Oct. 27 Endologix, Inc. (Nasdaq: ... disorders, today announced financial results for the three and ... McDermott, Endologix President and Chief Executive Officer, said, "Our ... sales of new products by our domestic sales force ...
Cached Medicine Technology:Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 2Endologix Reports 47% Third Quarter 2009 Revenue Growth 2Endologix Reports 47% Third Quarter 2009 Revenue Growth 3Endologix Reports 47% Third Quarter 2009 Revenue Growth 4Endologix Reports 47% Third Quarter 2009 Revenue Growth 5Endologix Reports 47% Third Quarter 2009 Revenue Growth 6Endologix Reports 47% Third Quarter 2009 Revenue Growth 7Endologix Reports 47% Third Quarter 2009 Revenue Growth 8
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers ... Committee of Massachusetts , and the Multicultural AIDS Coalition $3.78 million for ... who have sex with men (MSM) and transgender women, the groups at highest ...
(Date:7/7/2015)... ... 2015 , ... Illinois cannabis cultivation centers and dispensary owners ... The Medical Cannabis Alliance of Illinois’ (MCAI) board and its members have a ... making sure patients have access to cannabis as a viable medical treatment option. ...
(Date:7/7/2015)... ... , ... Safe Catch is setting revolutionary purity limits for canned tuna as ... Leaf Community Markets, Sprouts Farmers Market and Wegmans are some of the first grocers ... fish for mercury,” said Safe Catch co-founder Sean Wittenberg. “We launched Safe Catch tuna ...
(Date:7/7/2015)... Michigan (PRWEB) , ... July 07, 2015 , ... On ... fundraising golf outing at the Manistee Golf and Country Club. Best Drug Rehabilitation staff ... to a good cause, helping underprivileged children. Kiwanis International, the parent of the Manistee ...
(Date:7/7/2015)... ... July 07, 2015 , ... Georgia Partnership for TeleHealth ... throughout Georgia, announces the launch of the first ambulance telemedicine program in the ... GA. The new program will not only provide more immediate patient care, but ...
Breaking Medicine News(10 mins):Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2
... participate in clinical trials expect that their personal information ... Dr. Khaled El-Emam, Canada Research Chair in Electronic Health ... security practices used to transfer and share sensitive files ... Strong Are Passwords Used to Protect Personal Health Information ...
... 2011 − One of the tough challenges a parent faces ... the surviving children, and the task begins immediately, according to ... their child dies, parents are faced with the two extremes ... child and the ongoing, daily demands from their surviving children, ...
... studies on the screening and treatment of genitourinary cancers were ... Symposium, being held February 17-19, 2011, at the Orlando World ... studies were highlighted in a media presscast (press briefing via ... risk of prostate cancer death for men with low initial ...
... -- Men with prostate cancer may be twice as likely to ... of 20 than those without prostate cancer, a new French study ... or 40s do not appear to face a similar boost in ... 20s do not face a higher risk of developing the cancer ...
... costs ordered for 2,068 orthopaedic patient encounters in Pennsylvania were ... today at the 2011 Annual Meeting of the American Academy ... now, some physicians have ordered specific diagnostic procedures that are ... protect themselves from a lawsuit. Until now, however, efforts ...
... at the age of 20 are more likely to develop prostate ... disease, according to a new study published online in the cancer ... French study compared 388 men being treated for prostate cancer with ... with the disease were twice as likely as the healthy men ...
Cached Medicine News:Health News:Study reveals security weaknesses in file-sharing methods used in clinical trials 2Health News:Parenting after the death of a child a difficult balancing act: York U study 2Health News:Research presented at 2011 GU Cancers Symposium highlights advances in treatment of prostate cancer 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 2Health News:Could Hair Loss at 20 Signal Higher Prostate Cancer Risk? 3Health News:Health care spending: Study shows high imaging costs for defensive purposes 2Health News:Health care spending: Study shows high imaging costs for defensive purposes 3Health News:Losing hair at 20 is linked to increased risk of prostate cancer in later life 2Health News:Losing hair at 20 is linked to increased risk of prostate cancer in later life 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: